Use of corticosteroids in nephrology — risk and prevention of osteoporosis induction
- 1 May 2000
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 15 (5) , 565-568
- https://doi.org/10.1093/ndt/15.5.565
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The role of vitamin D in corticosteroid-induced osteoporosis: A meta-analytic approachArthritis & Rheumatism, 1999
- Prevention of corticosteroid-induced osteoporosis: Results of a patient surveyArthritis & Rheumatism, 1999
- Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?Kidney International, 1999
- Prophylactic Use of Alfacalcidol in Corticosteroid-Induced OsteoporosisOsteoporosis International, 1999
- Skeletal Unloading Causes Resistance of Osteoprogenitor Cells to Parathyroid Hormone and to Insulin-like Growth Factor-IJournal of Bone and Mineral Research, 1999
- Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.Journal of Clinical Investigation, 1998
- TREATMENT OF OSTEOPENIA AND OSTEOPOROSIS AFTER KIDNEY TRANSPLANTATIONTransplantation, 1998
- Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.Journal of Clinical Investigation, 1998
- Role of alfacalcidiol on bone quality and immunomodulation in autoimmune disease and organ transplantationCalcified Tissue International, 1997
- Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosisArthritis & Rheumatism, 1996